Accessibility Menu
Drägerwerk Ag & KGaA logo

Drägerwerk Ag & KGaA(OTC) DGWPF

Market Cap$1.74BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)+58%
5 Year+16%
1 Year+68%
1 Month+16%
$93.00
+0.00%
+0.00Today
Drägerwerk Ag & KGaA last closing stock price
MetricPriceDate
Last closeUSD 93.002026-07-30
Drägerwerk Ag & KGaA stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+15.66%USD 80.412026-06-03
1 month+15.66%USD 80.412026-06-03
3 month+25.23%USD 74.272026-04-27
Year to date+33.33%USD 69.752025-12-16
1 year+68.42%USD 55.222025-07-23
3 year+162.2%USD 35.472023-06-29
5 year+15.82%USD 80.302021-07-26
Since inception+57.63%USD 59.002016-08-23

Drägerwerk Ag & KGaA Financials at a Glance

Market Cap

$1.74BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€3.58B

Net Income (TTM)

€170.69M

EPS (TTM)

$10.65

P/E Ratio

8.74

Dividend

$2.59

Beta (Volatility)

0.06 (Low)

Price

$93.00

Volume

100

Open

$93.00

Previous Close

$93.00

Daily Range

$93.00 - $93.00

52-Week Range

$57.00 - $93.00

Estimated Earnings Date

Oct 29, 2026

DGWPF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Drägerwerk Ag & KGaA

Drägerwerk AG & Co. KGaA is a global leader in medical and safety technology, serving customers across various regions. The company specializes in innovative solutions for acute patient care and safety equipment, catering to diverse industries.

Products and Services
  • Comprehensive medical devices including anesthesia machines and ventilators
  • Safety solutions for personal protection and gas detection
  • Specialized software and training programs for healthcare and safety professionals
Growth Outlook
  • Revenue growth of 3.5% year-over-year in the latest quarter
  • Strong demand for medical devices driven by global healthcare needs
  • Expansion into emerging markets expected to enhance market share
Financial Highlights
  • Recent quarterly revenue of €758.74 million, reflecting robust performance
  • Trailing twelve months (TTM) net income margin of 4.36%
  • Dividend yield of 2.58%, indicating a commitment to shareholder returns
Drägerwerk AG & Co. KGaA has established itself as a key player in the medical and safety technology sectors. The company's diverse product offerings cater to critical healthcare needs and safety requirements across various industries. Recent financial performance indicates a solid revenue trajectory, with a notable increase in quarterly revenue and a healthy net income margin. The company's commitment to innovation and expansion into emerging markets positions it well for future growth. Additionally, the attractive dividend yield reflects a focus on delivering value to shareholders. Overall, Drägerwerk AG & Co. KGaA presents a compelling opportunity for investors interested in the healthcare and safety technology sectors.
AI Generated • Jul 17, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

16,682

CEO

Stefan Dräger

Website

www.draeger.com

Headquarters

Lübeck, SH 23558, DE

DGWPF Financials

Key Financial Metrics (TTM)

Gross Margin

34.90%

Operating Margin

7.69%

Net Income Margin

4.77%

Return on Equity

10.92%

Return on Capital

11.73%

Return on Assets

5.39%

Earnings Yield

11.44%

Dividend Yield

2.79%

Payout Ratio

21.96%

Stock Overview

Market Cap

$1.74BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

18.76M

Volume

100

Avg. Volume

4.286

Financials (TTM)

Gross Profit

€1.25B

Operating Income

€274.86M

EBITDA

€379.01M

Operating Cash Flow

€244.73M

Capital Expenditure

-€84.25M

Free Cash Flow

€160.50M

Cash & ST Invst.

€270.11M

Total Debt

€226.53M

Drägerwerk Ag & KGaA Performance Analysis

Drägerwerk Ag & KGaA annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 3,200,455,365-18.6%
20232023-12-31EUR 3,647,147,81114.0%
20242024-12-31EUR 3,646,249,737-0.0%
20252025-12-31EUR 3,929,593,3097.8%
Drägerwerk Ag & KGaA sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.0%
Q42025-12-3136.3%
Q12026-03-31-33.3%
Q22026-06-3011.5%
Drägerwerk Ag & KGaA annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -3.62N/A
20232023-12-31EUR 6.36N/A
20242024-12-31EUR 7.1812.8%
20252025-12-31EUR 8.4017.1%
Drägerwerk Ag & KGaA sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30218.3%
Q42025-12-31164.4%
Q12026-03-31-87.9%
Q22026-06-30152.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€846.03M

+8.5%

Gross Profit

€0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.74BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$112.97K

N/A

Employees

15,444

N/A

Net Income

€28.86M

+156.3%

EBITDA

€45.83M

-9.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€270.11M

-7.2%

Total Debt

€226.53M

-15.9%

Accounts Receivable

€811.43M

+13.8%

Inventory

€702.26M

-1.5%

Long Term Debt

€201.69M

+30.7%

Short Term Debt

€24.84M

-78.4%

Return on Assets

5.39%

N/A

Return on Invested Capital

12.25%

N/A

Free Cash Flow

€38.06M

-8.4%

Operating Cash Flow

€62.24M

+11.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDRSFMedartis Holding AG
$115.00+0.00%
BITGFBiotage AB (publ)
$15.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About DGWPF

What is the current price of Drägerwerk Ag & KGaA?

Drägerwerk Ag & KGaA is trading at $93.00 per share.

What is the 52-week range for Drägerwerk Ag & KGaA?

Over the past 52 weeks, Drägerwerk Ag & KGaA has traded between $57.00 and $93.00.

How much debt does Drägerwerk Ag & KGaA have?

As of the most recent reporting period, Drägerwerk Ag & KGaA reported total debt of €444.03M.

How much cash does Drägerwerk Ag & KGaA have on hand?

Drägerwerk Ag & KGaA reported €226.90M in cash and cash equivalents in its most recent financial results.

What is Drägerwerk Ag & KGaA’s dividend yield?

Drägerwerk Ag & KGaA currently has a dividend yield of 2.79%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services